Shankar Ramaswamy, MD

Shankar Ramaswamy is the Co-Founder, Chairman and Chief Executive Officer of Kriya, a bio­phar­ma­ceu­ti­cal company developing and man­u­fac­tur­ing one-time gene therapies aiming to treat prevalent chronic diseases. Dr. Ramaswamy is regarded as one of the leading innovators in the field of biotech­nol­o­gy, having been involved in the scaling of multiple high-growth companies. 

Prior to Kriya, Dr. Ramaswamy was part of the early foun­da­tion­al team at Roivant Sciences, which pioneered a novel subsidiary-based model to rapidly accelerate the development and com­mer­cial­iza­tion of medicines. In his time at Roivant, Dr. Ramaswamy was part of the team responsible for identifying and evaluating potential pipeline candidates and launching its first public subsidiary company, Axovant Sciences. He led corporate development at Axovant, where he played a critical role in the execution of the company’s initial public offering in 2015, raising over $360 million in what was at the time the largest biotech IPO in history.

Dr. Ramaswamy received his Medical Degree from Brown University and his under­grad­u­ate degree in Economics from Harvard University. He has been the recipient of multiple industry awards, having been named the Triangle Business Journal Life Sciences Awards CEO of the Year in 2022 and one of the 2023 Pharma Voice 100 Trail­blaz­ers shaping tomorrow’s pharma landscape.